Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non–small-cell Lung Cancer

Lung cancer is the leading cause of cancer deaths in both men and women in the United States accounting for about 27% of all cancer deceases. In our effort to develop newer therapy for lung cancer, we evaluated the combinatory antitumor effect of siRNA targeting VEGF and the PI3K/mTOR dual inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Espana-Serrano, Laura, Chougule, Mahavir B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155322/
https://www.ncbi.nlm.nih.gov/pubmed/27845769
http://dx.doi.org/10.1038/mtna.2016.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155322/
https://www.ncbi.nlm.nih.gov/pubmed/27845769
http://dx.doi.org/10.1038/mtna.2016.90

Ejemplares similares